EffPha – An expert-based CRO for your drug development
Exhibitor: EFFICIENT PHARMA MANAGEMENT CORP.
Date: 2025-06-26
Booth No.: M919
Efficient Pharma Management Corp. (EffPha) is a full-service CRO providing drug development services, including strategic and technical consulting, biostatistics, data management, regulatory dossier preparation and submission, and clinical study management and monitoring.
EffPha has established a team of experts with over 30 years of drug development experience from global pharmaceutical companies since founded. That EffPha is an expert-based CRO is the brand positioning by providing advice based on practical industry experience from domestic and international new drug development companies.
We knew an experienced and talented drug development team can not only provide decision-makers with the best strategies of drug development, advise and direct clinical operations, but also identify potential risks in drug development, which allows them to further plan risk management or adjust the direction of product development. Therefore, it would help shorten drug development timelines and mitigate risks for biotech and pharmaceutical companies, allocating development resources more efficiently.
EffPha excels at proposing the most suitable drug development strategies, designing clinical trials with high success rates, and providing high-quality clinical trial monitoring and management for the purpose of providing clients with the most efficient services. In recent years, clinical trials have tended to be conducted in multiple countries. In response, EffPha has set its sights on the global market. EffPha has taken the initiative to build a global presence, expand CRO services for international multi-center clinical trials, and move forward with our long-term collaborative pharmaceutical partners.
Visit us to learn how EffPha can help support your drug development projects at https://www.effpha.com/.
More Exhibitor's Press Release
- EffPha meets you at BIO Asia- Taiwan Exhibition 2025 EFFICIENT PHARMA MANAGEMENT CORP. / 2025-06-26
- GoldenBiotech Seminar:Advancing First-Line Therapy for Metastatic Pancreatic Cancer: Global Phase 3 GOLDEN BIOTECHNOLOGY CORP. / 2025-06-26
- FullGreen Unveils LNP Platform to Boost API Absorption & Revolutionize Pharma/Nutraceuticals FULLGREEN SUSTAINABLE BIOMEDICAL TECHNOLOGY CO.,LTD / 2025-06-26
- FullGreen Debuts Next-Gen API Synthesis & Smart QC Platform, Ushering in Efficient Pharma Production FULLGREEN SUSTAINABLE BIOMEDICAL TECHNOLOGY CO.,LTD / 2025-06-26
- The Ultimate Boost for Aesthetic Brands—Redefining the Limits of Ceramide Applications! FULLGREEN SUSTAINABLE BIOMEDICAL TECHNOLOGY CO.,LTD / 2025-06-26
- Panlabs Biologics Expands Functional Bioactive Ingredient Portfolio to Empower Biotech-Based Beauty PANLABS BIOLOGICS INC. / 2025-06-25
- Panlabs Biologics Partners with ATRI to Introduce Pichia pastoris Expression System, Strengthening L PANLABS BIOLOGICS INC. / 2025-06-25
- New Launch! IPI Pathoslide® 2.0 – Redefining Slide Coverslipping for Modern Labs J & H TECHNOLOGY CO., LTD. / 2025-06-25
- Unireal Technology to Exhibit High-Performance Japanese Processing Equipment at BIO Asia–Taiwan 2025 UNIREAL TECHNOLOGY CO., LTD / 2025-06-24
- Reagent Dispenser — Biodisp-1 MEDCLUB SCIENTIFIC CO., LTD. / 2025-06-24
- TaiMed at BIO Asia 2025: Advancing Long-Acting HIV Therapy and Innovative ADC Platform TAIMED BIOLOGICS INC. / 2025-06-24
- Professional Sample Preparation Before Sequencing Overall Solution MEDCLUB SCIENTIFIC CO., LTD. / 2025-06-24
- See Clearly, Count Accurately-Leap-Count Cell Counter Launched MEDCLUB SCIENTIFIC CO., LTD. / 2025-06-24
- Microbial CRO R&D Service Platform (Strain Optimization / Process Development) PANLABS BIOLOGICS INC. / 2025-06-23
- IOT無線連續監測系統 - 廠房、倉儲、實驗室 溫、濕度測繪 XIN TOP CORPORATION / 2025-06-23
- Uncountable Welcomes BlueNalu as a New Customer, Advancing The Future of Cell-Cultured Seafood UNCOUNTABLE INC. / 2025-06-20
- Mission and Value Proposition of Ducolege Biotechnology DUCOLEGE BIOTECHNOLOGY CO., LTD. / 2025-06-18
- NTHU team achieves breakthrough in breast cancer chemoresistant targeted therapy LILY WANG LAB NTHU / 2025-06-18
- Developing novel therapeutics for Alzheimer’s disease and neurodegenerative disorders NEURAL REJUVENATION TEAM, ACADEMIA SINICA / 2025-06-18
- Innovative Microfluidic Liquid Biopsy System Offers a New Solution for Colorectal Cancer Recurrence CELLENVISION COMPANY LIMITED / 2025-06-18